Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by ALLERGAN SALES LLC

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
016455 New Drug Application Approval New formulation (S) Standard review drug
017362 New Drug Application Approval New manufacturer (S) Standard review drug
017439 New Drug Application Approval New manufacturer (S) Standard review drug
017441 New Drug Application Approval New manufacturer (P) Priority review drug
017534 New Drug Application Approval New manufacturer (S) Standard review drug
017565 New Drug Application Approval New manufacturer (S) Standard review drug
017566 New Drug Application Approval New manufacturer (S) Standard review drug
017743 New Drug Application Approval New formulation (S) Standard review drug
019429 New Drug Application Approval New combination (S) Standard review drug
019594 New Drug Application Approval New molecular entity (NME) (P) Priority review drug (V) Orphan drug
019795 New Drug Application Approval New formulation (P) Priority review drug
020092 New Drug Application Approval New manufacturer (S) Standard review drug
020489 New Drug Application Approval New formulation (S) Standard review drug
020504 New Drug Application Approval New formulation (S) Standard review drug
020529 New Drug Application Approval New formulation (S) Standard review drug
020616 New Drug Application Approval New formulation (S) Standard review drug
020655 New Drug Application Approval New manufacturer (S) Standard review drug
020701 New Drug Application Approval New formulation (S) Standard review drug
020715 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
021288 New Drug Application Approval New formulation (S) Standard review drug
021351 New Drug Application Approval New formulation (S) Standard review drug
022204 New Drug Application Approval New formulation (S) Standard review drug
022206 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
022437 New Drug Application Approval New formulation (S) Standard review drug
040099 Abbreviated New Drug Application Approval
040148 Abbreviated New Drug Application Approval
086069 Abbreviated New Drug Application Approval
090098 Abbreviated New Drug Application Approval
202209 Abbreviated New Drug Application Approval
202211 New Drug Application Approval OTC (over-the-counter) switch (S) Standard review drug
202513 New Drug Application Approval New manufacturer (S) Standard review drug
205223 New Drug Application Approval New manufacturer (S) Standard review drug

Back to Companies who have applied for FDA Drug Approval